Explicit|04|60|191..196|1,1,1,0,1,1,1|still|||still|||Comparison.Contrast||||Ot|Comm|Null|Null|135..165|1,0;1,1,0;1,2|The biotechnology concern said|26..131|0,1,1|the government of Spain approved the marketing of its Proleukin interleukin-2 drug to treat kidney cancer|Ot|Comm|Null|Null|9..25|0,0;0,1,0;0,2|Cetus Corp. said|166..190;197..230|1,1,1,0,0;1,1,1,0,1,0;1,1,1,0,1,1,0;1,1,1,0,1,1,2|Spanish authorities must clear the price for the treatment|Inh|Null|Null|Null|||||||||
Explicit|04|60|232..235|1,1,1,2|but|||but|||Expansion.Conjunction||||Ot|Comm|Null|Null|135..165|1,0;1,1,0;1,2|The biotechnology concern said|166..230|1,1,1,0|Spanish authorities must still clear the price for the treatment|Inh|Null|Null|Null||||236..288|1,1,1,3|that it expects to receive such approval by year end|Inh|Null|Null|Null|||||||||
Implicit|04|60||||290|2||also||Expansion.Conjunction||||Wr|Comm|Null|Null||||135..288|1|The biotechnology concern said Spanish authorities must still clear the price for the treatment, but that it expects to receive such approval by year end|Inh|Null|Null|Null||||290..361|2|Four other countries in Europe have approved Proleukin in recent months|Inh|Null|Null|Null|||||||||
Implicit|04|60||||363|3||also||Expansion.Conjunction||||Wr|Comm|Null|Null||||290..361|2|Four other countries in Europe have approved Proleukin in recent months|Inh|Null|Null|Null||||363..449|3|Cetus is currently trying to obtain federal regulatory clearance for U.S. distribution|Inh|Null|Null|Null|||||||||
